Contraindications to vasoconstrictors in dentistry: Part II

. Compend Contin Educ Dent 1987;8:446.32. Forest D. Avec ou saris vasoconstricteur [Editorial]. J DentQuebec 1987;26:111.33. Huang AS, Fraser WN. Are sulfite additives really safe?[Letter]. N Engl J Med 1984;311:542.34. Bush RK, Taylor SL, Busse W. A critical evaluation of clin-ical trials in reactions to sulfites. J Allergy Clin Immunol1986;78:191-201.35. PCrusse R, Goulet JP, Turcotte JY. Sulfites, asthma and vas-oconstrictors. Can Dent Assoc J 1989;55:55-6. 36. Bush RK, Taylor SL, Holden K, Nordlee JA, Busse WW.Prevalence of sensitivity to sulfiting agents in asthmaticpatients. Am J Med 1986;81:816-20.37. Goldfarb G, Simon RA. Provocation of sulfite sensitive asthma (Abstract 107). J Allergy Clin Immunol 1984;73:135.38. Schwartz HJ, Sher TH. Bisulfite sensitivity manifesting as anallergy to dental anesthesia. J Allergy Clin Immunol 1985;751525-7.39. Baker GJ, Allen DH. The spectrum of metabisulphite inducedasthmatic reactions: their diagnosis and management. ThoracSot Aust 1982;12:213-6.40. Williams RH. Textbook of endocrinology. 5th ed. Philadel-phia: WB Saunders, 1974:306-15.41. Havlik RJ, Cahow E, Kinder BK. Advances in the diagnosisand treatment of pheochromocytoma.Arch Surg 1988;123:626-30.42. Hurst JW. The heart. 5th ed. New York: McGraw-Hill,1982:1559-60.43. Lansberg L, Young JB. In: Harrison’s principles of internalmedicine. 5th ed. New York: McGraw-Hill,1983:657-61.44. Smith GN, Walton RE. Periodontal ligament injection: distri-bution of injected solutions. ORAL SURG ORAL MED ORAL PATHOL 1983;55:232-8.45. Rawson RD, Orr DL. Vascular penetration following intrali-gamental injection. J Oral Maxillofac Surg 1985;43: 600-4.46. Smith GN, Pashley DH. Periodontal ligament injection: eval-uation of systemic effects. ORAL SURG ORAL MED ORAL PATHOL 1983;56:571-4.